Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-06

Clinical Trial Update: Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome

View source ↗

Summary

This clinical trial is evaluating CYTOFLAVIN intravenous solution and CYTOFLAVIN tablets for rehabilitation in patients with post-intensive care syndrome, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTOFLAVIN Intravenous Solution (CYTOFLAVIN)
  • CYTOFLAVIN Tablets (CYTOFLAVIN)

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Ischemic Stroke | Status: RECRUITING